Replicate vs. 2×2×2 (ethics?) [Regulatives / Guidelines]

posted by nobody – 2017-05-08 16:52 (2834 d 09:51 ago) – Posting: # 17317
Views: 23,262

❝ ❝ … and not as a result of outliers


❝ Nobody knows how to deal with this story. :-( Regulations  science. Not required by the FDA…


... sorry, no.

But this "it's safe because it has been shown to be safe in clinical practice over the last decades"-argumentation (question one above) never really went well in EU, I guess. At least you need to write a new, Chapter 2.5-like overview on the pk, pharmacology, safety to make the assessor sleep well next night after reading your application for a generic. On the other hand, assessors for originator's MAs have a much, much better sleep (better sleeping pills?), in my experience...


Edit: Please don’t shout! [Helmut]

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
245 visitors (0 registered, 245 guests [including 13 identified bots]).
Forum time: 01:44 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5